Literature DB >> 19288191

Up-regulation of epithelial membrane protein-1 in the temporal neocortex of patients with intractable epilepsy.

Yu-Qin Li1, Tao Xue, Liang Wang, Zu-Cai Xu, Zhi-Qin Xi, Jie Yuan, Xue-Feng Wang, Yang-Mei Chen, Meilin Zhang, Lan Yao.   

Abstract

Epithelial membrane protein-1 (EMP-1), called Tumor-associated membrane protein, is the marker of a drug-resistant tumor and take part in the drug-resistant mechanism of tumor, with the relationship of epidermal growth factor receptor (EGFR). Because there are some similarities between the pathogenesis and the drug resistance mechanism of tumor and the drug resistance mechanisms in epilepsy. EMP1 expression may be connected with the drug-resistance mechanism of epilepsy. We detected EMP-1 by gene scanning and immunohistochemistry staining, comparing the IE group and the control group, and we investigated the relationship between EMP-1 and EGFR by double-label immunofluorescence staining in the IE group. We found expression of EMP-1 mRNA was higher in IE per the gene scanning, EMP-1 immunoreactivity was apparent in neurons of IE patients but not in the control group, and the expression of EMP-1 and EGFR occurred in the same neuron. We confirm EMP-1 is abnormally expressed in IE and suggest the interaction of EGFR and EMP-1 plays a role in the mechanism of drug resistance in epilepsy and may be a new gene for drug resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288191     DOI: 10.1007/s11064-009-9948-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  Epithelial membrane protein-1 is a biomarker of gefitinib resistance.

Authors:  Anjali Jain; Charles A Tindell; Isett Laux; Jacob B Hunter; John Curran; Anna Galkin; Daniel E Afar; Nina Aronson; Steven Shak; Ronald B Natale; David B Agus
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

2.  Embryonic expression of epithelial membrane protein 1 in early neurons.

Authors:  P Wulf; U Suter
Journal:  Brain Res Dev Brain Res       Date:  1999-09-06

3.  Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins.

Authors:  I Ben-Porath; N Benvenisty
Journal:  Gene       Date:  1996-12-12       Impact factor: 3.688

Review 4.  Molecular and cellular mechanisms of pharmacoresistance in epilepsy.

Authors:  Stefan Remy; Heinz Beck
Journal:  Brain       Date:  2005-11-29       Impact factor: 13.501

5.  cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family.

Authors:  Y Chen; A Medvedev; P Ruzanov; K W Marvin; A M Jetten
Journal:  Genomics       Date:  1997-04-01       Impact factor: 5.736

6.  Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.

Authors:  S M Sisodiya; W-R Lin; B N Harding; M V Squier; M Thom
Journal:  Brain       Date:  2002-01       Impact factor: 13.501

Review 7.  Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain.

Authors:  I Ferrer; S Alcántara; J Ballabriga; M Olivé; R Blanco; R Rivera; M Carmona; M Berruezo; S Pitarch; A M Planas
Journal:  Prog Neurobiol       Date:  1996-06       Impact factor: 11.685

Review 8.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

Review 9.  STAT-mediated EGFR signaling in cancer.

Authors:  Kelly M Quesnelle; Amanda L Boehm; Jennifer R Grandis
Journal:  J Cell Biochem       Date:  2007-10-01       Impact factor: 4.429

10.  Involvement of p38alpha in kainate-induced seizure and neuronal cell damage.

Authors:  Kana Namiki; Akira Nakamura; Mitsuko Furuya; Satomi Mizuhashi; Yuji Matsuo; Naoki Tokuhara; Tatsuhiko Sudo; Hiroshi Hama; Tomoyuki Kuwaki; Shingo Yano; Sadao Kimura; Yoshitoshi Kasuya
Journal:  J Recept Signal Transduct Res       Date:  2007       Impact factor: 2.092

View more
  3 in total

1.  EMP-1 promotes tumorigenesis of NSCLC through PI3K/AKT pathway.

Authors:  Senyan Lai; Guihua Wang; Xiaonian Cao; Zhaoming Li; Junbo Hu; Jing Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

2.  Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy Whitten; Adi L Tarca; Gaurav Bhatti; Sorin Draghici; Piya Chaemsaithong; Jezid Miranda; Sonia S Hassan
Journal:  J Perinat Med       Date:  2013-09-01       Impact factor: 1.901

3.  New differentially expressed genes and differential DNA methylation underlying refractory epilepsy.

Authors:  Xi Liu; Shu Ou; Tao Xu; Shiyong Liu; Jinxian Yuan; Hao Huang; Lu Qin; Hui Yang; Lifen Chen; Xinjie Tan; Yangmei Chen
Journal:  Oncotarget       Date:  2016-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.